Tekla Capital's funds extend buyback through 2023

Mar. 22, 2022 10:37 AM ETTekla Life Sciences Investors (HQL), THW, HQH, THQBy: Shweta Agarwal, SA News Editor13 Comments
  • Tekla Capital's managed funds have announced one-year extension of their stock buyback program to now expire on June. 14, 2023.
  • It comes from Tekla Healthcare Opportunities Fund (THQ +0.6%), Tekla Healthcare Investors (HQH +1.3%), Tekla World Healthcare Fund (THW +0.7%), and Tekla Life Sciences Investors (HQL +0.4%).
  • Overall, the program allows to repurchase up to 12% of fund's outstanding common shares in the open market.

Recommended For You

Comments (13)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.